Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • FIR against Hetero and...

    FIR against Hetero and Aurobindo pharma

    Written by Ruby Khatun Khatun Published On 2017-10-07T13:36:56+05:30  |  Updated On 7 Oct 2017 1:36 PM IST
    FIR against Hetero and Aurobindo pharma

    HYDERABAD: 13 pharmaceutical companies have got notices from Telangana State Pollution Control Board (TSPCB) for contaminating and polluting Kazipally lake and Gaddapotharam lake by discharging the chemical waste of their plants in these lakes a recent report in TOI has stated.


    The notices were served on the companies after the preliminary confirmation was given by the PCB officials that the chemical contaminations of the lakes due to chemical discharges of the pharma companies are responsible for the death of fish in large numbers. The samples were taken and sent to the PCB central laboratory in Sanatnagar for conducting the laboratory tests for which results are still waiting.


    After getting a complaint from the fisheries cooperative society of Gandigudem, FIR was filed against the pharma companies in Kazipally and Gaddapotharam industrial areas situated along the drain including Hetro pharma, Aurobindo pharma and Divis labs by Ameenpur police after which preliminary examination was done by Telangana State Pollution Control Board.


    The confirmation of the same was given by environmental engineer K Ravi Kumar , Ramachandrapuram Pollution Control Board (PCB) regional office to TOI who informed that notices were served on Mylan Labs, SMS Pharma, DSDF Ramky, Kekule Pharma, Yag Mag pharma, Virchow pharma and Leepharma for Kazipally lake contamination and Rakshi Pharma, Vivin Lab, Mahalakshmi, Mekalab, Veda and Southwhale for contamination in Gaddapotharam lake .


    Speaking to the daily, He further said, “Notice has been served under section 33A of the Water (Prevention and Control of Pollution) Act 1974 on these 13 companies after physical inspection. The companies Hetero, Aurobindo and Vantech, which were named in the FIR by Ameenpur police following a complaint by the fisheries cooperative society of Gandigudem, are not in the list as we did not find harmful discharges from these companies. Other companies such as Sriram Pharma, MNR and Divis that we inspected on Thursday are also not in the list for the same reason. However, all these companies situated along the drain will be called for hearing and asked to explain the remedial measures they need to take.”

    Aurobindo Pharmachemical contaminationchemical dischargesDivis LabsFIRGaddapotharam lakeHealthcareHeteroindian pharma newsK Ravi KumarKazipally lakeP Satyanarayana Reddypharma newspharma news indiaTelangana State Pollution Control BoardTSPCBWater Prevention and Control of Pollution Act
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok